Results 311 to 320 of about 14,670,208 (357)
Some of the next articles are maybe not open access.
Therapeutic Drug Monitoring of Antiarrhythmic Drugs
Clinical Pharmacokinetics, 2003Most antiarrhythmic drugs fulfil the formal requirements for rational use of therapeutic drug monitoring, as they show highly variable plasma concentration profiles at a given dose and a direct concentration-effect relationship. Therapeutic ranges for antiarrhythmic drugs are, however, often very poorly defined.
Gesche, Jürgens +2 more
openaire +2 more sources
Drug level monitoring of antiasthmatic drugs
Journal of Chromatography B: Biomedical Sciences and Applications, 1985In general assays pertaining to drug level monitoring (DLM) of antiasthmatic agents (except theophylline), published during the period 1978-1983, used mostly high-performance liquid chromatographic (HPLC) methodology (approximately 45%) with mass spectrometric (MS) based assays in second place (approximately 30%) followed by immunochemical techniques ...
N, Kucharczyk, F H, Segelman
openaire +2 more sources
Drug monitoring in the elderly
Clinical Biochemistry, 1986Although the gut changes markedly with age no important differences in drug absorption have yet been demonstrated for any of a wide variety of drugs. Alterations in body structure and function can have important consequences on drug distribution in the elderly.
openaire +2 more sources
Problems in Therapeutic Drug Monitoring
Therapeutic Drug Monitoring, 1988Historically, it has been assumed that only free drug concentration is the pharmacologically active species. This article reviews the theoretical pharmacological and pharmacokinetic justifications for monitoring free drug levels. The determinants likely to influence plasma protein binding and the free concentrations of drugs are delineated.
J, Barre +3 more
openaire +2 more sources
Therapeutic Drug Monitoring of the Antimycobacterial Drugs
Clinics in Laboratory Medicine, 1996Because MDR tuberculosis and MAC are difficult to treat, TDM with the antimycobacterial drugs has become the standard of practice at NJC. By combining specific and sensitive assays, carefully collected samples, and clinical expertise, we are able to control and optimize antimycobacterial drug therapy.
openaire +2 more sources
Advances in drug monitoring and therapeutic drug monitoring
Analytical Proceedings, 1992David L. Colbert +4 more
openaire +1 more source
Antibody–Drug Conjugates: Smart Chemotherapy Delivery Across Tumor Histologies
Ca-A Cancer Journal for Clinicians, 2022Shanu Modi +2 more
exaly
16 Therapeutisches Drug Monitoring Drug Monitoring
2021Jan Dreher, Verena Lucas
openaire +1 more source

